What insurance policy changes affect CPT 64657?

There are 18 tracked policy changes affecting CPT 64657, including updates from Anthem BCBS, CareSource, Medical Mutual of Ohio. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for CPT 64657?

Payers that have issued tracked updates for CPT 64657 include: Anthem BCBS, CareSource, Medical Mutual of Ohio, Blue Cross NC, Humana.

How do I get notified when CPT 64657 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to CPT 64657. You will receive a daily digest email whenever a new policy change references this code.

Why do payers change policies for CPT 64657?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

64657 — Removing an implanted battery device that powers a nerve stimulation system completely.: Insurance Policy Changes

64657 Insurance Policy Changes

CPT 64657, in plain terms, covers Removing an implanted battery device that powers a nerve stimulation system completely. CPT 64657 is referenced in 18 tracked payer policy changes from Anthem BCBS, CareSource, and 3 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 64657 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Medium impact

Transcatheter and Device-Based Hemodynamic Management Procedures - Medicare Advantage (Revised)

Humana·Effective Aug 3, 2026

Humana Medicare Advantage updated its policy on transcatheter and device-based hemodynamic management procedures effective 08/03/2026. The policy clarifies coverage criteria for implantable carotid sinus baroreflex activation therapy (BAT) for heart failure, requires enrollment in approved IDE studies or strict clinical criteria including LVEF ≤35% and specific biomarker thresholds, and references CMS National Coverage Determinations for pulmonary artery pressure sensors and renal denervation procedures. All services must meet medical necessity standards and contraindication exclusions.

64657 Insurance Policy Changes

[Ohio] Precertification/prior authorization requirement changes

[California] Precertification/prior authorization requirement changes

[Virginia] Prior authorization requirement changes

[Virginia] Precertification/prior authorization requirement changes

[Georgia] Precertification/prior authorization list change notification

[California] Prior authorization requirement changes

[California] Prior authorization requirement changes

[New York] Precertification/prior authorization requirement changes

[Ohio] Precertification/prior authorization requirement changes

[Georgia] Precertification/prior authorization requirement changes

[New York] Precertification/prior authorization list change notification

[Virginia] Precertification/prior authorization list change notification

[Ohio] Precertification/prior authorization list change notification

[Georgia] Prior Authorization Requirement Update

Mutual News May 2026 Newsletter

Medical Policy Update December 31, 2025

Transcatheter and Device-Based Hemodynamic Management Procedures - Medicare Advantage (Revised)

Transcatheter and Device-Based Hemodynamic Management Procedures - Medicare Advantage (Revised)